Free Trial

Alvotech (ALVO) Competitors

Alvotech logo
$8.52 -0.21 (-2.41%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$8.60 +0.08 (+0.94%)
As of 07/11/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALVO vs. QGEN, VTRS, ASND, MRNA, BBIO, BPMC, VRNA, ROIV, ELAN, and RVMD

Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Qiagen (QGEN), Viatris (VTRS), Ascendis Pharma A/S (ASND), Moderna (MRNA), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry.

Alvotech vs. Its Competitors

Alvotech (NASDAQ:ALVO) and QIAGEN (NYSE:QGEN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

70.0% of QIAGEN shares are owned by institutional investors. 0.5% of Alvotech shares are owned by insiders. Comparatively, 9.0% of QIAGEN shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Alvotech has a net margin of 16.42% compared to QIAGEN's net margin of 4.68%. QIAGEN's return on equity of 14.61% beat Alvotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Alvotech16.42% -36.37% 12.70%
QIAGEN 4.68%14.61%8.80%

Alvotech presently has a consensus target price of $18.00, suggesting a potential upside of 111.27%. QIAGEN has a consensus target price of $49.40, suggesting a potential upside of 2.64%. Given Alvotech's stronger consensus rating and higher possible upside, equities analysts plainly believe Alvotech is more favorable than QIAGEN.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alvotech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
QIAGEN
0 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.30

In the previous week, Alvotech had 12 more articles in the media than QIAGEN. MarketBeat recorded 16 mentions for Alvotech and 4 mentions for QIAGEN. QIAGEN's average media sentiment score of 0.70 beat Alvotech's score of 0.67 indicating that QIAGEN is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alvotech
2 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QIAGEN
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alvotech has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, QIAGEN has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.

QIAGEN has higher revenue and earnings than Alvotech. Alvotech is trading at a lower price-to-earnings ratio than QIAGEN, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.98M5.22-$231.86M$0.3723.03
QIAGEN$1.98B5.41$83.59M$0.40120.33

Summary

QIAGEN beats Alvotech on 11 of the 16 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVO vs. The Competition

MetricAlvotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.63B$2.97B$5.62B$9.10B
Dividend YieldN/A2.39%5.24%4.00%
P/E Ratio23.0320.7128.1320.27
Price / Sales5.22288.38428.2998.73
Price / CashN/A42.8637.4658.16
Price / Book-6.227.638.045.49
Net Income-$231.86M-$55.05M$3.18B$250.45M
7 Day Performance-7.29%8.43%3.62%4.78%
1 Month Performance-13.41%5.42%4.06%7.67%
1 Year Performance-29.88%2.03%30.01%16.43%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALVO
Alvotech
2.7018 of 5 stars
$8.52
-2.4%
$18.00
+111.3%
-28.5%$2.63B$491.98M23.031,032
QGEN
Qiagen
3.6975 of 5 stars
$48.07
+0.6%
$49.40
+2.8%
+20.4%$10.62B$1.98B120.525,765
VTRS
Viatris
2.9016 of 5 stars
$8.93
-0.9%
$10.40
+16.5%
-18.5%$10.57B$14.74B-2.8232,000
ASND
Ascendis Pharma A/S
3.5819 of 5 stars
$172.60
+0.2%
$220.67
+27.8%
+28.9%$10.53B$393.54M-27.481,017News Coverage
Analyst Forecast
MRNA
Moderna
4.309 of 5 stars
$27.59
+1.6%
$46.61
+68.9%
-72.6%$10.50B$3.24B-3.165,800Trending News
BBIO
BridgeBio Pharma
4.585 of 5 stars
$43.18
-3.7%
$58.85
+36.3%
+72.8%$8.52B$221.90M-12.23400Analyst Upgrade
High Trading Volume
BPMC
Blueprint Medicines
1.2248 of 5 stars
$128.18
+0.1%
$128.06
-0.1%
+9.8%$8.27B$508.82M-51.89640Positive News
Insider Trade
VRNA
Verona Pharma PLC American Depositary Share
2.3736 of 5 stars
$94.58
+0.8%
$101.10
+6.9%
+394.0%$7.99B$42.28M-47.2930Trending News
Analyst Forecast
ROIV
Roivant Sciences
2.8383 of 5 stars
$11.27
-1.1%
$17.50
+55.3%
+1.1%$7.74B$29.05M-45.08860Analyst Upgrade
ELAN
Elanco Animal Health
1.5099 of 5 stars
$14.29
flat
$15.17
+6.1%
+9.0%$7.10B$4.44B19.319,000News Coverage
RVMD
Revolution Medicines
4.5764 of 5 stars
$36.79
-0.3%
$67.58
+83.7%
-12.3%$6.88B$11.58M-9.20250

Related Companies and Tools


This page (NASDAQ:ALVO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners